MultiOmic Health has built a platform for discovering and developing life-changing precision medicines for age-related chronic multifactorial diseases where genetics alone cannot explain why numerous patients continue to progress despite being treated on standard of care.

Our initial focus is the cardio-renal-metabolic landscape, a group of closely-related conditions constituting the world’s costliest healthcare burden, consuming $2 trillion in global healthcare costs in 2019 (1.6 times more than cancer) and forecasted to exceed $5.5 trillion by 2040. Our first platform use case is chronic kidney disease (CKD).

Using our unique combination of deep longitudinal patient datasets, AI-enabled data science capabilities and experimental biology expertise, we identify patient subpopulations having their own distinct molecular-level disease drivers. Our precision medicine platform spawns new treatments for these patient subpopulations, whose clinical trials will be smaller and shorter while yielding higher success rates compared to historical programmes in this disease space.

We aim to transform the clinical landscape by aligning research & development approaches with the emerging treatment paradigm to deliver holistic care in cardio-renal-metabolic. We have started building a global CRM patient registry that will be capturing over 100,000 patients by 2028. Our long-term mission is to become the preeminent central knowledge engine in this space.